
- Ophthalmology Times Europe November 2023
- Volume 19
- Issue 09
- Pages: 26 - 27
Recap: The latest data and innovations from the 2023 EURETINA congress
The highlights from this year’s meeting, brought to you in conjunction with Modern Retina
Retina specialists from around the globe attended the 23rd annual EURETINA congress, held this year in Amsterdam, the Netherlands, 5 – 8 October. The meeting’s in-person and virtual components enabled attendees in Europe and beyond to learn about the latest advancements in retina care, through case studies, exclusive poster presentations and cutting-edge symposia. This year’s congress included the inaugural EURETINA Innovation Spotlight (EIS), a 6-hour event that brought attention to industry leaders through a series of panel discussions and networking events, along with the robust programme of presentations and papers.
To cover this year’s meeting, Ophthalmology Times Europe teamed up with
Emerging therapies for exudative AMD
The landscape of retinal care is constantly changing. One area where new treatments are rapidly emerging is exudative age-related macular degeneration (AMD). Arshad M. Khanani, MD, MA, FASRS,
Dr Ali Erginay speaks about advancements in ultrawidefield imaging
Dr Ali Erginay spoke with our team about
Samsung Bioepis presents a post hoc analysis of the phase 3 clinical study results for SB15
Samsung Bioepis
Positive phase 3 DIAMOND trial results for OCS-01 in DME unveiled
Ramin Tadayoni, MD, PhD,
Safety and efficacy through week 48 in the phase 2a STARLIGHT clinical trial
We spoke with Michael Singer, MD, who provided an overview of his work with Nanoscope Therapeutics. He also shared details on his EURETINA presentation, “MCO-010 Optogenetic Therapy to Treat Stargardt Disease: Safety and Efficacy through Week 48 in the Phase 2a STARLIGHT Clinical Trial.”
LEAD study: Reducing AMD progression rates with subthresold nanosecond laser in eyes with no pseudodrusen
Data from an earlier study prompted the question: could a nonthermal (very short pulse) laser targeting the retinal pigment epithelium (RPE) be designed to specifically trigger a rejuvenating response in the RPE? Investigators from the LEAD study
Dr Varun Chaudhary discusses posturing after macular hole surgery
Ahead of the meeting, Varun Chaudhary, MD,
Articles in this issue
almost 2 years ago
Harnessing digital media for enhanced patient engagement and outcomesalmost 2 years ago
Looking past the eye in paediatric noninfectious uveitisalmost 2 years ago
Machine learning: A view from new angles